Title: Deep vein thrombosis
1Venous Thromboembolism
Treatment
- Deep vein thrombosis
- Pulmonary embolism
All the same?
2Acute DVT
Management
What is the goal of therapy?
3Acute DVT
Therapeutic Goals/Options
Caval Filter
Anticoagulation
Thrombolytic Rx
Thrombectomy
No Rx
Reduce PE
X
X
X
X
Prevent Extension
X
X
Reduce Recurrence
X
X
Restore Patency
X
X
Preserve Valve Function
X
X
Reduce CVI
X
X
4Isolated Calf DVT
51 patients randomized Rx
Heparin x 5 days
Heparin x 5 days Warfarin x 3 mos
No recurrent VTE
29 recurrent VTE
19 proximal DVT
4 pulmonary emboli
Langerstedt CI, et al. Lancet 1985.
5Deep Vein Thrombosis
Treatment
- Initial treatment
- Importance of therapeutic levels
- Compression
- Ambulation
- Long-term treatment
- 5 patient categories
6Acute DVT
Importance of Early Rx
Recurrent VTE
PTT lt1.5x (24 hrs.)
24.5
(151)
PTT gt1.5x
1.6
lt0.001
most occur gt 4 weeks association with poor
initial response not appreciated by
attending MDs
Hull, RD et al NEJM 1990
7Heparin/LMWH Bioavailability
Heparin for Acute DVT
Plasma Level After SQ - Volunteers
Single Subcutaneous Injection
Plasma Recovery
LMWH
90
Unfractionated heparin (UFH)
20
Bratt G, et al. Thromb Rea 198642(5)613-620.
Bara L, et al. Thromb Res. 198539(5)631-636.
8LMWH vs. UFH for Acute DVT
A Meta-Analysis of 10 Studies (n759)
- Prospective
- Adjusted dose unfractionated heparin
- Fixed dose SQ LMWH
- Objective outcome measures
- Symptomatic recurrent DVT
- Change in thrombus size
- Major bleeding
- Mortality
Bratt G, et al. Thromb Rea 198642(5)613-620.
Bara L, et al. Thromb Res. 198539(5)631-636.
9LMWH vs. UFH for Acute DVT
A Meta-Analysis of 10 Studies (n759)
Risk Reduction
UFH
LMWH
P-value
Venographic Change
6.5
3.1
53
lt0.01
52
63
-
Improved
12
6
lt0.001
Worse
Major Bleed
2.8
0.8
68
lt0.005
Mortality
7.1
3.9
47
lt0.04
Lensing AWA, et al Arch Intern Med 1995
10Deep Vein Thrombosis
Initial Treatment Compression Ambulation
- Proximal DVT- 53 patients
- LMWH...then randomize
- Bed rest
- Ambulation 35 mm Hg stocking
- Ambulation 50 mm Hg compression bandage
- Activity measured - pedometer
- Venous duplex days 0 9
1. Blattler W., et al Intl Angiol. 2003 32
861-9 2. Partsch H. et al J Vasc Surg 2000
32 861-9